Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT06613191
Colonoscopy and Antiplatelet Therapy Trial (CAPTT)
P2Y12 Inhibitor Versus Aspirin Monotherapy in Patients Undergoing Elective Screening and Surveillance Colonoscopy
Sponsor: Ochsner Health System
Interventions
Aspirin P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel)
Updated 1 time since 2024 Last updated: Sep 23, 2024 Started: Oct 1, 2024 Primary completion: Dec 31, 2025 Completion: Jun 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Coronary Arterial Disease (CAD) and Peripheral Vascular Disease and is currently actively recruiting participants. Ochsner Health System leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Ochsner Health System
Data source: Ochsner Health System
For direct contact, visit the study record on ClinicalTrials.gov .